Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]Y Yuana, A Sturk and R Nieuwland: Extracellular vesicles in physiological and pathological conditions. Blood Rev, 27(1), 31-9 (2013)

  • [2]B Gyorgy, TG Szabo, M Pasztoi, Z Pal, P Misjak, B Aradi, V Laszlo, E Pallinger, E Pap, A Kittel, G Nagy, A Falus and EI Buzas: Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci, 68(16), 2667-88 (2011)

  • [3]E van der Pol, AN Boing, P Harrison, A Sturk and R Nieuwland: Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev, 64(3), 676-705 (2012)

  • [4]SM van Dommelen, P Vader, S Lakhal, SA Kooijmans, WW van Solinge, MJ Wood and RM Schiffelers: Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. J Control Release, 161(2), 635-44 (2012)

  • [5]S Mathivanan and RJ Simpson: ExoCarta: A compendium of exosomal proteins and RNA. Proteomics, 9(21), 4997-5000 (2009)

  • [6]RJ Simpson, SS Jensen and JW Lim: Proteomic profiling of exosomes: current perspectives. Proteomics, 8(19), 4083-99 (2008)

  • [7]H Valadi, K Ekstrom, A Bossios, M Sjostrand, JJ Lee and JO Lotvall: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol, 9(6), 654-9 (2007)

  • [8]E Cocucci, G Racchetti and J Meldolesi: Shedding microvesicles: artefacts no more. Trends Cell Biol, 19(2), 43-51 (2009)

  • [9]MC Deregibus, V Cantaluppi, R Calogero, M Lo Iacono, C Tetta, L Biancone, S Bruno, B Bussolati and G Camussi: Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood, 110(7), 2440-8 (2007)

  • [10]J Ratajczak, M Wysoczynski, F Hayek, A Janowska-Wieczorek and MZ Ratajczak: Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia, 20(9), 1487-95 (2006)

  • [11]M Baj-Krzyworzeka, R Szatanek, K Weglarczyk, J Baran, B Urbanowicz, P Branski, MZ Ratajczak and M Zembala: Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother, 55(7), 808-18 (2006)

  • [12]W Losche, T Scholz, U Temmler, V Oberle and RA Claus: Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets, 15(2), 109-15 (2004)

  • [13]R Safaei, BJ Larson, TC Cheng, MA Gibson, S Otani, W Naerdemann and SB Howell: Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther, 4(10), 1595-604 (2005)

  • [14]K Shedden, XT Xie, P Chandaroy, YT Chang and GR Rosania: Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res, 63(15), 4331-7 (2003)

  • [15]K Al-Nedawi, B Meehan, RS Kerbel, AC Allison and J Rak: Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A, 106(10), 3794-9 (2009)

  • [16]HF Heijnen, AE Schiel, R Fijnheer, HJ Geuze and JJ Sixma: Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood, 94(11), 3791-9 (1999)

  • [17]O Morel, L Jesel, JM Freyssinet and F Toti: Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol, 31(1), 15-26 (2011)

  • [18]R Nieuwland: Cellular origin of microparticles exposing tissue factor in cancer: a mixed double? J Thromb Haemost, 6(9), 1514-6 (2008)

  • [19]AP Owens, 3rd and N Mackman: Microparticles in hemostasis and thrombosis. Circ Res, 108(10), 1284-97 (2011)

  • [20]K Schara, V Jansa, V Sustar, D Dolinar, JI Pavlic, M Lokar, V Kralj-Iglic, P Veranic and A Iglic: Mechanisms for the formation of membranous nanostructures in cell-to-cell communication. Cell Mol Biol Lett, 14(4), 636-56 (2009)

  • [21]C Thery, M Ostrowski and E Segura: Membrane vesicles as conveyors of immune responses. Nat Rev Immunol, 9(8), 581-93 (2009)

  • [22]AV Vlassov, S Magdaleno, R Setterquist and R Conrad: Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta, 1820(7), 940-8 (2012)

  • [23]K Denzer, MJ Kleijmeer, HF Heijnen, W Stoorvogel and HJ Geuze: Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci, 113 Pt 19, 3365-74 (2000)

  • [24]RF Zwaal and AJ Schroit: Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood, 89(4), 1121-32 (1997)

  • [25]K Trajkovic, C Hsu, S Chiantia, L Rajendran, D Wenzel, F Wieland, P Schwille, B Brugger and M Simons: Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science, 319(5867), 1244-7

  • [26]JH Hurley, E Boura, LA Carlson and B Rozycki: Membrane budding. Cell, 143(6), 875-87 (2010)

  • [27]JH Hurley and PI Hanson: Membrane budding and scission by the ESCRT machinery: it’s all in the neck. Nat Rev Mol Cell Biol, 11(8), 556-66 (2010)

  • [28]A Savina, M Furlan, M Vidal and MI Caolombo: Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem, 278(22), 20083-90 (2003)

  • [29]C Thery, A Regnault, J Garin, J Wolfers, L Zitvogel, P Ricciardi-Castagnoli, G Raposo and S Amigorena: Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol, 147(3), 599-610 (1999)

  • [30]G van Niel, G Raposo, C Candalh, M Boussac, R Hershberg, N Cerf-Bensussan and M Heyman: Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology, 121(2), 337-49 (2001)

  • [31]N Blanchard, D Lankar, F Faure, A Regnault, C Dumont, G Raposo and C Hivroz: TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol, 168(7), 3235-41 (2002)

  • [32]G Raposo, D Tenza, S Mecheri, R Peronet, C Bonnerot and C Desaymard: Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell, 8(12), 2631-45 (1997)

  • [33]RM Johnstone, M Adam, JR Hammond, L Orr and C Turbide: Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem, 262(19), 9412-20 (1987)

  • [34]S Pant, H Hilton and ME Burczynski: The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol, 83(11), 1484-94 (2012)

  • [35]M Record, C Subra, S Silvente-Poirot and M Poirot: Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol, 81(10), 1171-82 (2011)

  • [36]SA Bellingham, BB Guo, BM Coleman and AF Hill: Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Front Physiol, 3, 124 (2012)

  • [37]C Lasser, M Eldh and J Lotvall: Isolation and characterization of RNA-containing exosomes. J Vis Exp (59), e3037 (2012)

  • [38]DD Taylor and C Gercel-Taylor: Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol, 33(5), 441-54 (2011)

  • [39]J Conde-Vancells, E Rodriguez-Suarez, N Embade, D Gil, R Matthiesen, M Valle, F Elortza, SC Lu, JM Mato and JM Falcon-Perez: Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res, 7(12), 5157-66 (2008)

  • [40]C Subra, D Grand, K Laulagnier, A Stella, G Lambeau, M Paillasse, P De Medina, B Monsarrat, B Perret, S Silvente-Poirot, M Poirot and M Record: Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res, 51(8), 2105-20 (2010)

  • [41]O Moskovich and Z Fishelson: Live cell imaging of outward and inward vesiculation induced by the complement c5b-9 complex. J Biol Chem, 282(41), 29977-86 (2007)

  • [42]I Del Conde, CN Shrimpton, P Thiagarajan and JA Lopez: Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood, 106(5), 1604-11 (2005)

  • [43]A Piccin, WG Murphy and OP Smith: Circulating microparticles: pathophysiology and clinical implications. Blood Rev, 21(3), 157-71 (2007)

  • [44]U Salzer, P Hinterdorfer, U Hunger, C Borken and R Prohaska: Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood, 99(7), 2569-77 (2002)

  • [45]FI Hawari, FN Rouhani, X Cui, Z. X Yu, C Buckley, M Kaler and SJ Levine: Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc Natl Acad Sci U S A, 101(5), 1297-302 (2004)

  • [46]J Skog, T Wurdinger, S van Rijn, DH Meijer, L Gainche, M Sena-Esteves, WT Curry, Jr., BS Carter, AM Krichevsky and X O Breakefield: Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol, 10(12), 1470-6 (2008)

  • [47]C Yang, BR Mwaikambo, T Zhu, C Gagnon, J Lafleur, S Seshadri, P Lachapelle, JC Lavoie, S Chemtob and P Hardy: Lymphocytic microparticles inhibit angiogenesis by stimulating oxidative stress and negatively regulating VEGF-induced pathways. Am J Physiol Regul Integr Comp Physiol, 294(2), R467-76 (2008)

  • [48]M Wysoczynski and MZ Ratajczak: Lung cancer secreted microvesicles: underappreciated modulators of microenvironment in expanding tumors. Int J Cancer, 125(7), 1595-603 (2009)

  • [49]HA Mostefai, R Andriantsitohaina and MC Martinez: Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. Physiol Res, 57 (3), 311-20 (2008)

  • [50]HK Kim, KS Song, JH Chung, KR Lee and SN Lee: Platelet microparticles induce angiogenesis in vitro. Br J Haematol, 124(3), 376-84 (2004)

  • [51]A Brill, O Dashevsky, J Rivo, Y Gozal and D Varon: Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res, 67(1), 30-8 (2005)

  • [52]CM Boulanger and A Tedgui: Dying for attention: microparticles and angiogenesis. Cardiovasc Res, 67(1), 1-3 (2005)

  • [53]R Bonavia, MM Inda, S Vandenberg, SY Cheng, M Nagane, P Hadwiger, P Tan, DW Sah, WK Cavenee and FB Furnari: EGFRvIII promotes glioma angiogenesis and growth through the NF-kappaB, interleukin-8 pathway. Oncogene, 31(36), 4054-66 (2012)

  • [54]B Bussolati, C Grange and G Camussi: Tumor exploits alternative strategies to achieve vascularization. FASEB J, 25(9), 2874-82 (2011)

  • [55]A Janowska-Wieczorek, LA Marquez-Curtis, M Wysoczynski and MZ Ratajczak: Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion, 46(7), 1199-209 (2006)

  • [56]A Janowska-Wieczorek, M Wysoczynski, J Kijowski, L Marquez-Curtis, B Machalinski, J Ratajczak and MZ Ratajczak: Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer, 113(5), 752-60 (2005)

  • [57]H Peinado, M Aleckovic, S Lavotshkin, I Matei, B Costa-Silva, G Moreno-Bueno, M Hergueta-Redondo, C Williams, G Garcia-Santos, C Ghajar, A Nitadori-Hoshino, C Hoffman, K Badal, BA Garcia, MK Callahan, J Yuan, VR Martins, J Skog, RN Kaplan, MS Brady, JD Wolchok, PB Chapman, Y Kang, J Bromberg and D Lyden: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med, 18(6), 883-91 (2012)

  • [58]G Raposo, HW Nijman, W Stoorvogel, R Liejendekker, CV Harding, CJ Melief and HJ Geuze: B lymphocytes secrete antigen-presenting vesicles. J Exp Med, 183(3), 1161-72 (1996)

  • [59]L Frangsmyr, V Baranov, O Nagaeva, U Stendahl, L Kjellberg and L Mincheva-Nilsson: Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level. Mol Hum Reprod, 11(1), 35-41 (2005)

  • [60]L Mincheva-Nilsson, O Nagaeva, KG Sundqvist, ML Hammarstrom, S Hammarstrom and V Baranov: gammadelta T cells of human early pregnancy decidua: evidence for cytotoxic potency. Int Immunol, 12(5), 585-96 (2000)

  • [61]MJ Martinez-Lorenzo, A Anel, S Gamen, I Monlen, P Lasierra, L Larrad, A Pineiro, MA Alava and J Naval: Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol, 163(3), 1274-81 (1999)

  • [62]M Karlsson, S Lundin, U Dahlgren, H Kahu, I Pettersson and E Telemo: “Tolerosomes” are produced by intestinal epithelial cells. Eur J Immunol, 31(10), 2892-900 (2001)

  • [63]A Clayton, JP Mitchell, J Court, MD Mason and Z Tabi: Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res, 67(15), 7458-66 (2007)

  • [64]DD Taylor, S Akyol and C Gercel-Taylor: Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol, 176(3), 1534-42 (2006)

  • [65]A Sabapatha, C Gercel-Taylor and DD Taylor: Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol, 56(5-6), 345-55 (2006)

  • [66]L Mincheva-Nilsson, O Nagaeva, T Chen, U Stendahl, J Antsiferova, I Mogren, J Hernestal and V Baranov: Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J Immunol, 176(6), 3585-92 (2006)

  • [67]M Hedlund, AC Stenqvist, O Nagaeva, L Kjellberg, M Wulff, V Baranov and L Mincheva-Nilsson: Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol, 183(1), 340-51 (2009)

  • [68]J Wolfers, A Lozier, G Raposo, A Regnault, C Thery, C Masurier, C Flament, S Pouzieux, F Faure, T Tursz, E Angevin, S Amigorena and L Zitvogel: Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med, 7(3), 297-303 (2001)

  • [69]V Huber, S Fais, M Iero, L Lugini, P Canese, P Squarcina, A Zaccheddu, M Colone, G Arancia, M Gentile, E Seregni, R Valenti, G Ballabio, F Belli, E Leo, G Parmiani and L Rivoltini: Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology, 128(7), 1796-804 (2005)

  • [70]G Andreola, L Rivoltini, C Castelli, V Huber, P Perego, P Deho, P Squarcina, P Accornero, F Lozupone, L Lugini, A Stringaro, A Molinari, G Arancia, M Gentile, G Parmiani and S Fais: Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med, 195(10), 1303-16 (2002)

  • [71]R Valenti, V Huber, M Iero, P Filipazzi, G Parmiani and L Rivoltini: Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res, 67(7), 2912-5 (2007)

  • [72]L Mincheva-Nilsson and V Baranov: The role of placental exosomes in reproduction. Am J Reprod Immunol, 63(6), 520-33 (2010)

  • [73]S Guller: Role of the syncytium in placenta-mediated complications of preeclampsia. Thromb Res, 124(4), 389-92 (2009)

  • [74]B Toth, CA Lok, A Boing, M Diamant, JA van der Post, K Friese and R Nieuwland: Microparticles and exosomes: impact on normal and complicated pregnancy. Am J Reprod Immunol, 58(5), 389-402 (2007)

  • [75]CW Redman and IL Sargent: Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol, 76(1-2), 61-7 (2007)

  • [76]VM Abrahams, SL Straszewski-Chavez, S Guller and G Mor: First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod, 10(1), 55-63 (2004)

  • [77]MA Habiba, RF James, SC Bell and F Al-Azzawi: Identification of a cycle-modulated 200-kDa endometrial antigen by a monoclonal antibody LDS60. J Immunol Methods, 227(1-2), 65-73 (1999)

  • [78]YH Ng, S Rome, A Jalabert, A Forterre, H Singh, CL Hincks and LA Salamonsen: Endometrial exosomes/microvesicles in the uterine microenvironment: a new paradigm for embryo-endometrial cross talk at implantation. PLoS One, 8(3), e58502 (2013)

  • [79]G Burns, K Brooks, M Wildung, R Navakanitworakul, LK Christenson and TE Spencer: Extracellular vesicles in luminal fluid of the ovine uterus. PLoS One, 9(3), e90913 (2014)

  • [80]AG Braundmeier, CA Dayger, P Mehrotra, RJ Belton, Jr. and RA Nowak: EMMPRIN is secreted by human uterine epithelial cells in microvesicles and stimulates metalloproteinase production by human uterine fibroblast cells. Reprod Sci, 19(12), 1292-301 (2012)

  • [81]LA Burnett, MM Light, P Mehrotra and RA Nowak: Stimulation of GPR30 increases release of EMMPRIN-containing microvesicles in human uterine epithelial cells. J Clin Endocrinol Metab, 97(12), 4613-22 (2012)

  • [82]IM Saadeldin, SJ Kim, YB Choi and BC Lee: Improvement of cloned embryos development by co-culturing with parthenotes: a possible role of exosomes/microvesicles for embryos paracrine communication. Cell Reprogram, 16(3), 223-34 (2014)

  • [83]EM Rosenbluth, DN Shelton, LM Wells, AE Sparks and BJ Van Voorhis: Human embryos secrete microRNAs into culture media--a potential biomarker for implantation. Fertil Steril, 101(5), 1493-500 (2014)

  • [84]J Kropp, SM Salih and H Khatib: Expression of microRNAs in bovine and human pre-implantation embryo culture media. Front Genet, 5, 91 (2014)

  • [85]S Atay, C Gercel-Taylor, M Kesimer and DD Taylor: Morphologic and proteomic characterization of exosomes released by cultured extravillous trophoblast cells. Exp Cell Res, 317(8), 1192-202 (2011)

  • [86]S Atay, C Gercel-Taylor, J Suttles, G Mor and DD Taylor: Trophoblast-derived exosomes mediate monocyte recruitment and differentiation. Am J Reprod Immunol, 65(1), 65-77 (2011)

  • [87]S Atay, C Gercel-Taylor and DD Taylor: Human trophoblast-derived exosomal fibronectin induces pro-inflammatory IL-1beta production by macrophages. Am J Reprod Immunol, 66(4), 259-69 (2011)

  • [88]S Baig, JY Lim, AZ Fernandis, MR Wenk, A Kale, LL Su, A Biswas, S Vasoo, G Shui and M Choolani: Lipidomic analysis of human placental syncytiotrophoblast microvesicles in adverse pregnancy outcomes. Placenta, 34(5), 436-42 (2013)

  • [89]CW Redman, DS Tannetta, RA Dragovic, C Gardiner, JH Southcombe, GP Collett and IL Sargent: Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta, 33 Suppl, S48-54 (2012)

  • [90]RA Dragovic, C Gardiner, AS Brooks, DS Tannetta, DJ Ferguson, P Hole, B Carr, CW Redman, AL Harris, PJ Dobson, P Harrison and IL Sargent: Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine, 7(6), 780-8 (2011)

  • [91]SS Sidhu, AT Mengistab, AN Tauscher, J LaVail and C Basbaum: The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene, 23(4), 956-63 (2004)

  • [92]D Millimaggi, M Mari, S D’Ascenzo, E Carosa, EA Jannini, S Zucker, G Carta, A Pavan and V Dolo: Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia, 9(4), 349-57 (2007)

  • [93]O Alcazar, AM Hawkridge, TS Collier, SW Cousins, SK Bhattacharya, DC Muddiman and ME Marin-Castano: Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells. Mol Cell Proteomics, 8(10), 2201-11 (2009)

  • [94]CH Wang, H Yao, L N. Chen, JF Jia, L Wang, JY Dai, ZH Zheng, ZN Chen and P Zhu: CD147 induces angiogenesis through a vascular endothelial growth factor and hypoxia-inducible transcription factor 1alpha-mediated pathway in rheumatoid arthritis. Arthritis Rheum, 64(6), 1818-27 (2012)

  • [95]M Sato, Y Nakai, W Nakata, T Yoshida, K Hatano, A Kawashima, K Fujita, M Uemura, H Takayama and N Nonomura: EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome. PLoS One, 8(9), e74313 (2013)

  • [96]Y Lee, S El Andaloussi and MJ Wood: Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet, 21(R1), R125-34 (2012)

  • [97]LW Chamley, OJ Holland, Q Chen, CA Viall, PR Stone and M Abumaree: Review: where is the maternofetal interface? Placenta, 35 Suppl, S74-80 (2014)

  • [98]F Shen, J Wei, S Snowise, J DeSousa, P Stone, C Viall, Q Chen and L Chamley: Trophoblast debris extruded from preeclamptic placentae activates endothelial cells: A mechanism by which the placenta communicates with the maternal endothelium. Placenta, 35(10), 839-47 (2014)

  • [99]DS Tannetta, RA Dragovic, C Gardiner, CW Redman and IL Sargent: Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLoS One, 8(2), e56754 (2013)

  • [100]AE Chambers, PF Stanley, H Randeva and S Banerjee: Microvesicle-mediated release of soluble LH/hCG receptor (LHCGR) from transfected cells and placenta explants. Reprod Biol Endocrinol, 9, 64 (2011)

  • [101]LW Chamley, Q Chen, J Ding, PR Stone and M Abumaree: Trophoblast deportation: just a waste disposal system or antigen sharing? J Reprod Immunol, 88(2), 99-105 (2011)

  • [102]LM Chen, B Liu, HB Zhao, P Stone, Q Chen and L Chamley: IL-6, TNFalpha and TGFbeta promote nonapoptotic trophoblast deportation and subsequently causes endothelial cell activation. Placenta, 31(1), 75-80 (2010)

  • [103]MS Esplin, K Merrell, R Goldenberg, Y Lai, JD Iams, B Mercer, CY Spong, M Miodovnik, HN Simhan, P van Dorsten and M Dombrowski: Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol, 204(5), 391 e1-8 (2011)

  • [104]C Gardiner, DS Tannetta, CA Simms, P Harrison, CW Redman and IL Sargent: Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit increased tissue factor activity. PLoS One, 6(10), e26313 (2011)

  • [105]TH Hung, JN Skepper and GJ Burton: In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol, 159(3), 1031-43 (2001)

  • [106]J Southcombe, D Tannetta, C Redman and I Sargent: The immunomodulatory role of syncytiotrophoblast microvesicles. PLoS One, 6(5), e20245 (2011)

  • [107]DD Taylor, W Zacharias and C Gercel-Taylor: Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol, 728, 235-46 (2011)

  • [108]P Pantham, KJ Askelund and LW Chamley: Trophoblast deportation part II: a review of the maternal consequences of trophoblast deportation. Placenta, 32(10), 724-31 (2011)

  • [109]S Aschkenazi, S Straszewski, KM Verwer, H Foellmer, T Rutherford and G Mor: Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol Reprod, 66(6), 1853-61 (2002)

  • [110]G Mor, LS Gutierrez, M Eliza, F Kahyaoglu and A Arici: Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease. Am J Reprod Immunol, 40(2), 89-94 (1998)

  • [111]BS Holder, CL Tower, K Forbes, MJ Mulla, JD Aplin and VM Abrahams: Immune cell activation by trophoblast-derived microvesicles is mediated by syncytin 1. Immunology, 136(2), 184-91 (2012)

  • [112]E Hergenreider, S Heydt, K Treguer, T Boettger, AJ Horrevoets, AM Zeiher, MP Scheffer, AS Frangakis, X Yin, M Mayr, T Braun, C Urbich, RA Boon and S Dimmeler: Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol, 14(3), 249-56 (2012)

  • [113]SS Chim, TK Shing, EC Hung, TY Leung, TK Lau, RW Chiu and YM Lo: Detection and characterization of placental microRNAs in maternal plasma. Clin Chem, 54(3), 482-90 (2008)

  • [114]M Eldh, K Ekstrom, H Valadi, M Sjostrand, B Olsson, M Jernas and J Lotvall: Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA. PLoS One, 5(12), e15353 (2010)

  • [115]SS Luo, O Ishibashi, G Ishikawa, T Ishikawa, A Katayama, T Mishima, T Takizawa, T Shigihara, T Goto, A Izumi, A Ohkuchi, S Matsubara and T Takeshita: Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod, 81(4), 717-29 (2009)

  • [116]JM Moreno-Moya, F Vilella and C Simon: MicroRNA: key gene expression regulators. Fertil Steril, 101(6), 1516-23 (2014)

  • [117]JF Mouillet, RB Donker, T Mishima, T Cronqvist, T Chu and Y Sadovsky: The unique expression and function of miR-424 in human placental trophoblasts. Biol Reprod, 89(2), 25 (2013)

  • [118]RB Donker, JF Mouillet, T Chu, CA Hubel, DB Stolz, AE Morelli and Y Sadovsky: The expression profile of C19MC microRNAs in primary human trophoblast cells and exosomes. Mol Hum Reprod, 18(8), 417-24 (2012)

  • [119]E Shomer, S Katzenell, Y Zipori, RN Sammour, B Isermann, B Brenner and A Aharon: Microvesicles of women with gestational hypertension and preeclampsia affect human trophoblast fate and endothelial function. Hypertension, 62(5), 893-8 (2013)

  • [120]JM Roberts, LM Bodnar, KY Lain, CA Hubel, N Markovic, RB Ness and RW Powers: Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension, 46(6), 1263-9 (2005)

  • [121]AH Brandao, LM Pereira, AC Goncalves, ZS Reis, HV Leite and AC Cabral: Comparative study of endothelial function and uterine artery doppler velocimetry between pregnant women with or without preeclampsia development. J Pregnancy, 2012, 909315 (2012)

  • [122]K Matsubara, E Abe, H Ochi, Y Kusanagi and M Ito: Changes in serum concentrations of tumor necrosis factor alpha and adhesion molecules in normal pregnant women and those with pregnancy-induced hypertension. J Obstet Gynaecol Res, 29(6), 422-6 (2003)

  • [123]M Gauster and B Huppertz: The paradox of caspase 8 in human villous trophoblast fusion. Placenta, 31(2), 82-8 (2010)

  • [124]G Tsimerman, A Roguin, A Bachar, E Melamed, B Brenner and A Aharon: Involvement of microparticles in diabetic vascular complications. Thromb Haemost, 106(2), 310-21 (2011)

  • [125]L Petrozella, M Mahendroo, B Timmons, S Roberts, D McIntire and JM Alexander: Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period. Am J Obstet Gynecol, 207(2), 140 e20-6 (2012)

  • [126]S Katzenell, E Shomer, Y Zipori, A Zylberfisz, B Brenner and A Aharon: Characterization of negatively charged phospholipids and cell origin of microparticles in women with gestational vascular complications. Thromb Res, 130(3), 479-84 (2012)

  • [127]E Biro, CA Lok, CE Hack, JA van der Post, MC Schaap, A Sturk and R Nieuwland: Cell-derived microparticles and complement activation in preeclampsia versus normal pregnancy. Placenta, 28(8-9), 928-35 (2007)

  • [128]M Tattersall, N Engineer, S Khanjani, SR Sooranna, VH Roberts, PL Grigsby, Z Liang, L Myatt and MR Johnson: Pro-labour myometrial gene expression: are preterm labour and term labour the same? Reproduction, 135(4), 569-79 (2008)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

1 Jan 2016Review

Exosomes mediate embryo and maternal interactions at implantation and during pregnancy

Lindsey A. Burnett 1, Romana A. Nowak 2,*
Affiliations
Article Info

1 Medical Scholars Program, University of Illinois, Urbana, IL, 61801

2 Department of Animal Sciences, University of Illinois, Urbana, IL, 61801

*Author to whom correspondence should be addressed.

 

Abstract

Shedding of exosomes and microvesicles is now a well-recognized, important method of cell-cell communication in a number of different cell types. However, their importance in the female reproductive tract and in mediating embryo-maternal interactions during pregnancy has only recently been recognized. Here we review the current literature as to release of extracellular vesicles by uterine cells, the embryo, and placental trophoblast cells; how release is regulated; and the different types of signaling molecules and genetic information contained within such vesicles. We also discuss the role of these exosomes and microvesicles in regulating critical processes during implantation and pregnancy such as angiogenesis, matrix remodeling, alterations in immune function and pathological effects in gestational diseases. A better understanding of the role of exosomes and microvesicles in reproduction may lead to the development of new therapeutic approaches for treatment of infertility and pregnancy complications.

Keywords

  • Microvesicles
  • Exosomes
  • Uterus
  • Placenta
  • Review
  • Extracellular Vesicles
  • Review

References